The ASFA Board of Directors is pleased to announce the launch of the new ASFA Strategic Plan for 2018 - 2021.
The ASFA mission is to advance apheresis medicine for patients, donors and practitioners through
education, evidence-based practice, research and advocacy. Our vision is to be the leader in apheresis medicine.
Our organizational priorities for this Strategic Plan:
Promote the Qualification in Apheresis (QIA).
Increase research infrastructure and activity.
Position ASFA as the expert resource on apheresis to policy makers.
Increase international engagement and collaboration.